Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Jounce Therapeutics and Arvinas.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Jounce Therapeutics Jounce Therapeutics is a clinical-stage immunotherapy company.	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
Founding Date	Founding Date 2018	Founding Date 2013	Founding Date N/A
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare Technology healthtech oncology platform therapy	Tags Healthcare Technology drug development oncology pharma platform therapy
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Cambridge, US HQ	Locations New Haven, US HQ
Employees	Employees 188	Employees 1302% increase	Employees 13329% increase
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 101.6 m	Valuation ($) 1.9 b
Financial
Revenue (est.)	Revenue (est.) $36k (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $262.6m (FY, 2025)
Net income	Net income ($274.4m) (FY, 2025)	Net income ($50.9m) (FY, 2022)	Net income ($80.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 103m	Total funding raised $ 111.6m